NCT05422053View on ClinicalTrials.gov

Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions
Type 1 Diabetes
Interventions
DEVICE

t:slim X2 insulin pump with Control-IQ technology 1.5

t:slim X2 insulin pump with Control-IQ technology 1.5, and wearing the Dexcom G6 CGM.

Trial Locations (4)

55416

International Diabetes Center, Minneapolis

80045

Barbara Davis Center, Aurora

83404

Rocky Mountain Diabetes Center, Idaho Falls

84093

Diabetes & Endocrine Treatment Specialists, Sandy City

All Listed Sponsors
lead

Tandem Diabetes Care, Inc.

INDUSTRY